Pathkey.AI Ltd (ASX:PKY)

Market Cap	23.68M +411.5%
Revenue (ttm)	290.26K -60.3%
Net Income	-1.44M
EPS	-0.01
Shares Out	607.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	262,069
Open	0.0400
Previous Close	0.0390
Day's Range	0.0400 - 0.0410
52-Week Range	0.0140 - 0.0710
Beta	1.65
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 3, 2026

About Pathkey.AI

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathke...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PKY

Financial Performance

In fiscal year 2025, Pathkey.AI's revenue was 321,991, a decrease of -65.45% compared to the previous year's 932,076. Losses were -1.45 million, -53.75% less than in 2024.